Wake Pharma US, Inc. Announces the Appointment of Kim Eldridge as Coordinator & Clinical Wound Specialist Educator
Wake Pharma US, Inc. (Chicago, IL) is very pleased to announce the appointment of Kim Eldridge RNFA, CFCN, WCC as Coordinator & Clinical Wound Specialist Educator.
Kim Eldridge, Registered Nurse, with over 10 years of clinical experience in complex wound care, is a pioneer in the field of wound care; and is dedicated to providing the highest standards of care, improving clinical outcomes, emphasizing patient education, and ensuring healthcare accessibility and cost-efficiency.
Elk Grove Village, IL (PRWEB) November 13, 2009 --
Wake Pharma US, Inc., is a unique company that focuses production on low-cost, multilateral technologies that can provide a model and metaphor for saving money on personal healthcare. Wake Pharma US, Inc. advocates patient savvy, accountability, and responsibility, and is committed to advanced technology while making the patient the focal point.
Wake Pharma US, Inc. (Chicago, IL) is very pleased to announce the appointment of Kim Eldridge RNFA, CFCN, WCC as Coordinator & Clinical Wound Specialist Educator.
Kim Eldridge, Registered Nurse, was born and raised in Meridian, Mississippi, and has over 10 years of clinical experience in complex wound care. Her commitment to provide the highest standards of wound care, while improving clinical outcomes and emphasizing patient education, and her passion for ensuring healthcare accessibility and cost-efficiency, make Kim a pioneer in the field of wound care.
Kim has been a surgical nurse for over 17 years. She works exclusively with a general surgeon who specializes in wound care, hyperbaric therapy, and limb salvage. She provides surgical wound care in both acute and long term settings, and also consults for major wound care companies and organizations nationwide. She has published several posters and articles in the field of wound care education. Kim is a Registered Nurse First Assistant, and is a certified surgical, foot care and wound care nurse.
Maggie Jankowski, COO of Wake Pharma US, Inc. commented, “Kim Eldridge has been an invaluable resource to the Wound Be Gone® brand. Her clinical insight and experience has been a tremendous asset to our development team. We believe that Kim Eldridge, RN, will help us accelerate the growth of our product line.”
Kim Eldridge stated, “I am very pleased to accept the position of Coordinator & Clinical Wound Specialist Educator and to have the opportunity to contribute to the company’s clinical mission. My clinical experience with Wound Be Gone® has produced impressive results with improved wound healing trajectories. Wound Be Gone® is placing wound care into the hands of people who might otherwise suffer or whose wound problems might escalate to need for expensive, invasive medical intervention.”
Wound-Be-Gone® is a novel hydrophilic gel that has demonstrated enhanced wound healing in varied clinical settings with both acute and chronic wounds. The mechanism of action is related to a decrease in inflammatory mediators due to the active scavenging of oxygen free radicals. Visit www.woundbegone.com for more details.
About Wake Pharma US, Inc:
Wake Pharma US, Inc. is an innovative and international company with its own manufacturing facility located in the Czech Republic (European Union). Wake Pharma US, Inc specializes in developing, marketing and distribution of revolutionary and unique products to the health marketplace. For further information about Wake Pharma US, Inc please visit our website at www.wakepharmaus.com
###
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1Ib3JyLVN1bW0tSG9yci1FbXB0LVBpZ2ctWmVybw==
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
